Volume and price movement make it fairly obvious, no? Could it really be Silence again? You would have thought they would have learned not to gobble so quickly, there really is no need. Last time, when they went from 0 to 9% in about 2 weeks, driving PPS up to present levels or even 2.40, it then fell back to 1.50 or less, making complete clowns of them.
So, it seems there are 2 possibilities. Either it IS Silence, upping the 9% to 15-20%, in which case they want to become activist and have AP make a slight change to the delivery chemistry, that they consider important. My point is that the ST BoD would surely NOT go for having such a large proportion of their scarce capital in some small-cap biotech UNLESS there was a play that DIRECTLY involves their own (IP) business.
Or someone has got wind of the AD material and thinks it's bullish enough to buy in.
Since I know nothing of this but what seems obvious on ordinary business grounds, am asking if anyone else here knows, or suspects, anything more substantial?
I still do not think even my $5 strike 2018 LEAPs have a shot (how bloody well COULD they?), but these violent share trends make me curious.